Bank of America’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$251M Sell
476,998
-11,019
-2% -$6.18M 0.02% 682
2026
Q1
$274M Buy
488,017
+659
+0.1% +$423K 0.02% 595
2025
Q4
$330M Sell
487,358
-980
-0.2% -$667K 0.02% 537
2025
Q3
$312M Sell
488,338
-5,816
-1% -$3.53M 0.02% 608
2025
Q2
$265M Sell
494,154
-56,133
-10% -$26.8M 0.02% 667
2025
Q1
$231M Buy
550,287
+142,650
+35% +$61.9M 0.02% 666
2024
Q4
$169M Sell
407,637
-203,533
-33% -$89.3M 0.01% 754
2024
Q3
$309M Sell
611,170
-39,273
-6% -$19.1M 0.02% 552
2024
Q2
$317M Buy
650,443
+16,730
+3% +$8.4M 0.03% 501
2024
Q1
$342M Sell
633,713
-3,738
-0.6% -$2.04M 0.03% 474
2023
Q4
$354M Sell
637,451
-158,506
-20% -$74.4M 0.04% 432
2023
Q3
$348M Buy
795,957
+127,793
+19% +$63.7M 0.04% 411
2023
Q2
$336M Sell
668,164
-53,215
-7% -$25.5M 0.04% 419
2023
Q1
$361M Sell
721,379
-19,438
-3% -$9.3M 0.04% 432
2022
Q4
$302M Buy
740,817
+41,288
+6% +$16M 0.03% 460
2022
Q3
$228M Sell
699,529
-21,782
-3% -$8M 0.03% 524
2022
Q2
$253M Sell
721,311
-362,865
-33% -$148M 0.03% 505
2022
Q1
$593M Sell
1,084,176
-25,201
-2% -$13.3M 0.06% 306
2021
Q4
$730M Sell
1,109,377
-175,704
-14% -$110M 0.07% 270
2021
Q3
$799M Buy
1,285,081
+41,145
+3% +$27.6M 0.08% 225
2021
Q2
$786M Sell
1,243,936
-22,845
-2% -$12.6M 0.08% 231
2021
Q1
$620M Buy
1,266,781
+432,572
+52% +$217M 0.07% 265
2020
Q4
$417M Sell
834,209
-63,972
-7% -$28.6M 0.05% 319
2020
Q3
$353M Buy
898,181
+8,681
+1% +$3.21M 0.05% 336
2020
Q2
$294M Sell
889,500
-10,635
-1% -$3.08M 0.04% 356
2020
Q1
$218M Buy
900,135
+134,811
+18% +$35.2M 0.04% 392
2019
Q4
$200M Buy
765,324
+22,103
+3% +$5.82M 0.03% 498
2019
Q3
$202M Sell
743,221
-2,686
-0.4% -$747K 0.03% 482
2019
Q2
$205M Sell
745,907
-11,871
-2% -$2.92M 0.03% 471
2019
Q1
$169M Buy
757,778
+67,152
+10% +$13.9M 0.03% 533
2018
Q4
$128M Sell
690,626
-40,795
-6% -$8.36M 0.02% 569
2018
Q3
$183M Buy
731,421
+4,288
+0.6% +$1.04M 0.03% 500
2018
Q2
$158M Sell
727,133
-110,890
-13% -$22.8M 0.03% 523
2018
Q1
$160M Sell
838,023
-47,658
-5% -$8.8M 0.03% 528
2017
Q4
$139M Buy
885,681
+5,363
+0.6% +$844K 0.02% 601
2017
Q3
$137M Buy
880,318
+263,075
+43% +$41.6M 0.02% 620
2017
Q2
$99.6M Sell
617,243
-287,768
-32% -$46.7M 0.02% 701
2017
Q1
$140M Buy
905,011
+26,139
+3% +$3.6M 0.03% 553
2016
Q4
$103M Buy
878,872
+44,524
+5% +$5.08M 0.02% 652
2016
Q3
$94.1M Sell
834,348
-215,793
-21% -$22.7M 0.02% 665
2016
Q2
$97.5M Buy
1,050,141
+48,451
+5% +$4.16M 0.02% 634
2016
Q1
$78.5M Sell
1,001,690
-131,876
-12% -$9.5M 0.02% 714
2015
Q4
$82.7M Sell
1,133,566
-350,489
-24% -$25M 0.02% 754
2015
Q3
$110M Buy
1,484,055
+795,158
+115% +$57M 0.03% 605
2015
Q2
$44.2M Sell
688,897
-13,901
-2% -$962K 0.01% 921
2015
Q1
$54.3M Sell
702,798
-80,228
-10% -$6.24M 0.02% 784
2014
Q4
$58M Buy
783,026
+36,232
+5% +$2.54M 0.02% 778
2014
Q3
$44M Sell
746,794
-40,060
-5% -$2.53M 0.01% 909
2014
Q2
$52.5M Buy
786,854
+70,032
+10% +$4.45M 0.02% 804
2014
Q1
$43.5M Buy
716,822
+21,328
+3% +$1.27M 0.02% 824
2013
Q4
$37M Buy
695,494
+52,424
+8% +$2.76M 0.01% 912
2013
Q3
$32M Buy
643,070
+28,400
+5% +$1.36M 0.01% 937
2013
Q2
$27.6M Buy
+614,670
New +$26.9M 0.01% 993

Other funds holding IDXX

Bank of America's IDXX Position: Q2 2026 in Review

Bank of America reduced its Idexx Laboratories (IDXX) stake by 2.3% in Q2 2026, selling an estimated $6.18M and leaving 476,998 shares worth $251M. The position accounts for 0.02% of the portfolio, ranked #682.

Bank of America first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $799M in Q3 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Bank of America held 476,998 shares of Idexx Laboratories worth $251M as of Q2 2026.
  • Bank of America sold 11,019 Idexx Laboratories shares in Q2 2026, an estimated $6.18M.
  • Idexx Laboratories made up 0.02% of Bank of America's portfolio in Q2 2026, its #682 holding.
  • Bank of America first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Bank of America's Idexx Laboratories position peaked at $799M in Q3 2021.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.